Vol. 01 · Issue 001
Australia's Healthcare Pulse
AI, Pharma & Policy Intel
TGA AI guidance, GLP-1 reimbursement shifts, and AI scribes going mainstream
18 March 2026
This inaugural issue covers three domains across 15 strategic items — from the TGA's draft framework for AI-enabled medical devices to GLP-1 reimbursement pressures reshaping PBS policy debate, and AI scribes transitioning from limited pilots to mainstream hospital adoption across Australian health systems.
Issue Highlights
- TGA releases draft AI medical device guidance
- GLP-1 reimbursement pressure on PBS funding
- AI scribes: pilot → mainstream hospital adoption
- Retail pharmacy workforce crisis in regional areas
- Three biotech M&A deals: sector consolidation signals
- Drug discovery AI — two Phase II trial updates
Read Full Issue →
~12 min read